328 related articles for article (PubMed ID: 7999812)
21. Culture-negative CAPD peritonitis: the Network 9 Study.
Bunke M; Brier ME; Golper TA
Adv Perit Dial; 1994; 10():174-8. PubMed ID: 7999821
[TBL] [Abstract][Full Text] [Related]
22. The case for oral treatment of peritonitis in continuous ambulatory peritoneal dialysis.
Passadakis P; Oreopoulos D
Adv Perit Dial; 2001; 17():180-90. PubMed ID: 11510271
[TBL] [Abstract][Full Text] [Related]
23. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
24. Positive dialysate gram stain predicts outcome of empirical antibiotic therapy for peritoneal dialysis-associated peritonitis.
Lee CC; Sun CY; Chang KC; Wu MS
Ther Apher Dial; 2010 Apr; 14(2):201-8. PubMed ID: 20438543
[TBL] [Abstract][Full Text] [Related]
25. [Peritonitis in continuous ambulatory peritoneal dialysis: diagnosis and treatment].
Bénévent D; Lagarde C; Benzakour M
Nephrologie; 1989; 10 Suppl():43-5. PubMed ID: 2682310
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].
Bulut C; Oztürk R; Yilmaz GR; Parpucu H; Irmak H; Kinikli S; Duranay M; Demiröz AP
Mikrobiyol Bul; 2008 Apr; 42(2):255-64. PubMed ID: 18697423
[TBL] [Abstract][Full Text] [Related]
27. Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial.
Kitrungphaiboon T; Puapatanakul P; Chuengsaman P; Tiskajornsiri K; Halue G; Siribamrungwong M; Matayart S; Chongthanakorn K; Poonvivatchaikarn U; Boonyakrai C; Somboonsilp W; Katavetin P; Praditpornsilpa K; Eiam-Ong S; Johnson DW; Kanjanabuch T
Am J Kidney Dis; 2019 Nov; 74(5):601-609. PubMed ID: 31331757
[TBL] [Abstract][Full Text] [Related]
28. [Peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Evaluation of cephalothin/cephalexin monotherapy as initial treatment].
Hornstrup MK; Nielsen TG; Gahrn-Hansen B; Pedersen FB; Klausen M
Ugeskr Laeger; 1993 Nov; 155(45):3650-4. PubMed ID: 8256355
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD.
Vargemezis V; Thodis E; Pasadakis P; Martinis G; Kousta E
Adv Perit Dial; 1990; 6():123-5. PubMed ID: 1982788
[TBL] [Abstract][Full Text] [Related]
30. Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Szeto CC; Kwan BC; Chow KM; Law MC; Pang WF; Chung KY; Leung CB; Li PK
Am J Kidney Dis; 2009 Oct; 54(4):702-10. PubMed ID: 19577352
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of intraperitoneally administered gentamicin and rifampin as initial treatment of peritoneal dialysis-related peritonitis.
Brulez HF; Moncasi EP; Posthuma N; Choy K; ter Wee PM
Adv Perit Dial; 1995; 11():182-6. PubMed ID: 8534700
[TBL] [Abstract][Full Text] [Related]
32. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
33. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis.
Zurowska A; Feneberg R; Warady BA; Zimmering M; Monteverde M; Testa S; Calyskan S; Drozdz D; Salusky I; Kemper MJ; Ekim M; Verrina E; Misselwitz J; Schaefer F
Am J Kidney Dis; 2008 Mar; 51(3):455-62. PubMed ID: 18295061
[TBL] [Abstract][Full Text] [Related]
34. Vancomycin therapy for treatment of peritonitis in outpatients on peritoneal dialysis.
Yorioka N; Taniguchi Y; Ito T; Katsutani M; Amimoto D; Masaki T; Nishida Y; Kushihata S; Oda H; Yamakido M
Hiroshima J Med Sci; 1998 Sep; 47(3):105-7. PubMed ID: 9810781
[TBL] [Abstract][Full Text] [Related]
35. [Peritonitis in intermittent peritoneal dialysis: microbiological aspects and the antibiogram].
Romão Júnior JE; Fortes RM; Fadil MA; Gushi N; Vaz WS; Marcondes M; Sabbaga E
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):100-3. PubMed ID: 2616993
[TBL] [Abstract][Full Text] [Related]
36. Vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Beaman M; Solaro L; McGonigle RJ; Michael J; Adu D
Nephron; 1989; 51(1):51-5. PubMed ID: 2644565
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
[TBL] [Abstract][Full Text] [Related]
38. Pseudomonas peritonitis in CAPD patients: characteristics and outcome of treatment.
Chan MK; Chan PC; Cheng IP; Chan CY; Ng WS
Nephrol Dial Transplant; 1989; 4(9):814-7. PubMed ID: 2516614
[TBL] [Abstract][Full Text] [Related]
39. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
Searle M; Raman GV
Clin Nephrol; 1985 May; 23(5):241-4. PubMed ID: 4006333
[TBL] [Abstract][Full Text] [Related]
40. Acinetobacter peritonitis in patients receiving continuous ambulatory peritoneal dialysis.
Valdez JM; Asperilla MO; Smego RA
South Med J; 1991 May; 84(5):607-10. PubMed ID: 2035081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
